Drug discovery through genetic analysis of nature

Double Rainbow Biosciences is at the forefront of integrating advanced scientific disciplines such as genomics, metabolomics, and synthetic biology to innovate in the field of natural product manufacturing. The company focuses on creating sustainable therapeutic and nutraceutical solutions inspired by nature, leveraging the evolutionary adaptations of plants that utilize sugar as a molecular decoration. This unique approach enhances the solubility and potency of medicinal compounds, presenting significant opportunities for medical innovation. Their proprietary enzyme modification platform, PRISM, utilizes an extensive enzyme library to optimize the glycosylation of both novel and existing medicinal compounds, thereby improving their specificity and efficacy.

In addition to pharmaceutical applications, Double Rainbow is committed to addressing global challenges such as food insecurity through bioengineering solutions. Their technologies aim to create a sustainable supply of active pharmaceutical ingredients and rare consumer health ingredients while minimizing the environmental impact of agricultural practices. By harnessing synthetic biology, the company seeks to revolutionize the production of natural products, ensuring the preservation of vulnerable ecosystems and reducing the carbon footprint associated with food production. Through these efforts, Double Rainbow Biosciences is dedicated to promoting human health and ecological sustainability, redefining wellness in harmony with nature.

United States

Double Rainbow is leveraging the critical role of glycans in human biology to bioengineer anew class of glyco-drug conjugates (GDC) and deliver the next generation of precision medicines.

Double Rainbow Biosciences

Company Details